Furthermore, we found significant differences in clinicopathological characteristics (age, gender, fibrosis Ishak score, pathologic T, and race) between HSPA1A, NR1I3, PPARGC1A, and MAT1A gene expressions and hepatocellular carcinoma patients (Tables S9–S12). Here, NR1I3 is linked to hepatocellular carcinoma.